ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

EVG Evgen Pharma Plc

0.80
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 422k -4.04M -0.0147 -0.54 2.2M
Evgen Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 0.80p. Over the last year, Evgen Pharma shares have traded in a share price range of 0.75p to 4.05p.

Evgen Pharma currently has 274,888,117 shares in issue. The market capitalisation of Evgen Pharma is £2.20 million. Evgen Pharma has a price to earnings ratio (PE ratio) of -0.54.

Evgen Pharma Share Discussion Threads

Showing 1701 to 1724 of 13025 messages
Chat Pages: Latest  77  76  75  74  73  72  71  70  69  68  67  66  Older
DateSubjectAuthorDiscuss
05/5/2020
09:59
News coming soon.Gl :-)
moneymunch
05/5/2020
09:43
Looks on to close that gap but not counting chickens!
toffeeman
05/5/2020
08:33
Looking good and strong...Gla ;-)
moneymunch
04/5/2020
16:47
telegram group if anyone wants in
just started all help welcome

colin12345678
04/5/2020
16:32
Tomorrow would be nice
peanut100
04/5/2020
15:51
Looking good and strong...good news could drop at anytime. ;-)
moneymunch
04/5/2020
11:06
Perfectly poised for positive news...confirmation of the new CEO and an Update on SFX-01, very possibly for Covid treatment trials. Gla :-)
moneymunch
04/5/2020
11:04
And it doesn't look like it will here either!
toffeeman
04/5/2020
08:29
Couldn't get a spread bet on so bought a few to sell on the gap close (if it happens) - - it didn't with C4XD!!
toffeeman
04/5/2020
08:05
Looking good and strong!!! Gla holders On and UP!!! ;-)
moneymunch
01/5/2020
17:34
Back in again mid morning,more luck than judgement to catch the rise:)
NFX also up today.

bmnsa
01/5/2020
16:26
Don't blink then !
arab3
01/5/2020
16:24
See my post 1617, re French Bio.., maybe something similar in the pipeline for EVG. Gl :-)


Currently, there are no clinical studies on sulforaphane versus covid-19, "so we are forced to use therapeutic approaches based on previous research. Sulforaphane has been shown to be safe for consumption and that it is commercially available. I think it can be an important treatment available to the citizen in the current viral pandemic "continues the boss of the laboratory Nutrinov.

Nutrinov and its researchers therefore hope to be able to launch a clinical study to assess the efficacy of sulforaphane against the current virus.

moneymunch
01/5/2020
16:23
Hi Nobby :)
toffeeman
01/5/2020
16:19
Wow. You blink and you miss it...
nobbygnome
01/5/2020
16:17
Close the gap back to 16p for starters, news of new CEO coming, and if Sfx-01 is selected for clinical trials for Covid-19, then the sky's the limit. Gla :-)
moneymunch
01/5/2020
16:05
Wow another rocket going skyward, got CTEA this week (medical digital passports) and they have been flying nicely although they are so small I fancy they can go many times higher. What are the price expectations on Evgen?
czar
01/5/2020
15:37
Market short of stock, any news here Monday and massive squeeze.
peanut100
01/5/2020
15:28
10p plus close on the cards, fingers crossed for news this coming week. Gla :-)
moneymunch
01/5/2020
15:27
Just paid above the ask.
awise355
01/5/2020
13:29
Good luck with the new drug blakeysangel and glad to hear you are getting through lock down without the need of a divorce lawyer, unlike a lot of people during this time I suspect!
lovewinshatelosses
01/5/2020
12:31
Looking good and strong, confirmation of the new CEO is likely to add significant value, and news on their drug development collaborations with several Universities, who are all now heavily involved in Covid-19 treatment research, could drop at anytime, and if SFX-01 is confirmed as a likely candidate for Covid-19 trials, then this will fly. Gla :-)
moneymunch
01/5/2020
06:48
Translated from French to English...Gla ;-)

Coronanvirus: Nutrinov laboratory to launch research to evaluate the efficacy of sulforaphane

Thursday April 30

Around the world, the race is on to find treatments for the coronavirus. Near Rennes, a laboratory specializing in health and nutrition wants to launch a clinical trial on sulforaphane, a natural compound with antiviral properties.

Doctors often say, by being careful what you eat, people can ease their symptoms and heal faster. Several epidemiological studies have notably identified the important role of fruits and vegetables. A healthy diet and physical activity, for example, reduce the risk of cancer.

Some substances are known for their antiviral properties. One of them is of particular interest to researchers and scientists in the Nutrinov laboratory located near Reindeer. He specializes in health and nutrition. Its researchers are particularly interested in sulforaphane, present in cruciferous vegetables such as broccoli and kale. It has several properties that participate in cell protection. It has also been shown to have antiviral properties.

A prophylactic and curative effect against covid-19?

"This molecule there, we know that it has antiviral, antibacterial and anticancer properties. We have done clinical studies with people who had prostate cancer. We have shown that it can help slow the evolution of pathology "explain Dr. Bernard Cipolla, surgeon oncologist in urology and Théo Efstathiou who heads the Nutrinov Analyzes & Research laboratory.

"In terms of antiviral activity, we conducted another clinical study in 2014 on mice targeted to pulmonary edema. We injected the H1-N1 virus in mice. A fortnight before, we had given sulforaphane and we noticed a clear reduction in the symptoms of pulmonary edema "indicates Théo Efstathiou.

Currently, there are no clinical studies on sulforaphane versus covid-19, "so we are forced to use therapeutic approaches based on previous research. Sulforaphane has been shown to be safe for consumption and that it is commercially available. I think it can be an important treatment available to the citizen in the current viral pandemic "continues the boss of the laboratory Nutrinov.

Nutrinov and its researchers therefore hope to be able to launch a clinical study to assess the efficacy of sulforaphane against the current virus.

moneymunch
30/4/2020
17:06
(NADS in COVID-19 - short communication - version 1.1 - 1.5 A4 pages without references - 31.03.2020) Potent NRF2-activating dietary supplements (like resveratrol, curcumin, sulforaphane, “Asea redox supplement” [ARS] etc.) should be clinically tested as high-dose adjuvants in all types of medium and severe cases of aggressive respiratory viral infections (including Influenza A/B/C, measles, Coronavirus-related SARS, MERS, COVID-19) based on their extrapolated cytoprotective antioxidant effects


Abstract

This very short medical communication proposes that potent NRF2-activating dietary supplements (like resveratrol, sulforaphane, curcumin, “Asea redox supplement” [ARS] etc.) should be clinically tested as safe high-dose adjuvants (in various combinations) in all types of medium and severe cases of aggressive respiratory viral infections (including Influenza A/B/C, avian influenza, measles, Coronavirus-related SARS, MERS, COVID-19, etc., including those patients who have important comorbidities like HIV/AIDS, tuberculosis [TB] etc.) based on their extrapolated cytoprotective antioxidant effects (especially on the main vital organs: brain, heart, lungs, kidneys and liver), including the extrapolated strong cytoprotection offered by ARS on the cardiac muscle of DMD patients (which can be extrapolated to the lungs), like the author of this paper has demonstrated in past papers. Keywords: NRF2-activating dietary supplements, resveratrol, sulforaphane, curcumin, “Asea redox supplement” [ARS], respiratory viral infections, influenza A/B/C, avian influenza, measles, coronavirus, SARS, MERS, COVID-19, HIV/AIDS, tuberculosis [TB]

moneymunch
Chat Pages: Latest  77  76  75  74  73  72  71  70  69  68  67  66  Older

Your Recent History

Delayed Upgrade Clock